Literature DB >> 27328942

Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.

Rohan Samarakoon1, Alexandra Rehfuss2, Nidah S Khakoo3, Lucas L Falke4, Amy D Dobberfuhl5, Sevann Helo2, Jessica M Overstreet6, Roel Goldschmeding4, Paul J Higgins7.   

Abstract

Protein phosphatase magnesium-dependent-1A (PPM1A) dephosphorylates SMAD2/3, which suppresses TGF-β signaling in keratinocytes and during Xenopus development; however, potential involvement of PPM1A in chronic kidney disease is unknown. PPM1A expression was dramatically decreased in the tubulointerstitium in obstructive and aristolochic acid nephropathy, which correlates with progression of fibrotic disease. Stable silencing of PPM1A in human kidney-2 human renal epithelial cells increased SMAD3 phosphorylation, stimulated expression of fibrotic genes, induced dedifferentiation, and orchestrated epithelial cell-cycle arrest via SMAD3-mediated connective tissue growth factor and plasminogen activator inhibitor-1 up-regulation. PPM1A stable suppression in normal rat kidney-49 renal fibroblasts, in contrast, promoted a SMAD3-dependent connective tissue growth factor and plasminogen activator inhibitor-1-induced proliferative response. Paracrine factors secreted by PPM1A-depleted epithelial cells augmented fibroblast proliferation (>50%) compared with controls. PPM1A suppression in renal cells further enhanced TGF-β1-induced SMAD3 phosphorylation and fibrotic gene expression, whereas PPM1A overexpression inhibited both responses. Moreover, phosphate tensin homolog on chromosome 10 depletion in human kidney-2 cells resulted in loss of expression and decreased nuclear levels of PPM1A, which enhanced SMAD3-mediated fibrotic gene induction and growth arrest that were reversed by ectopic PPM1A expression. Thus, phosphate tensin homolog on chromosome 10 is an upstream regulator of renal PPM1A deregulation. These findings establish PPM1A as a novel repressor of the SMAD3 pathway in renal fibrosis and as a new therapeutic target in patients with chronic kidney disease.-Samarakoon, R., Rehfuss, A., Khakoo, N. S., Falke, L. L., Dobberfuhl, A. D., Helo, S., Overstreet, J. M., Goldschmeding, R., Higgins, P. J. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair. © FASEB.

Entities:  

Keywords:  CTGF; PAI-1; PTEN; TGF-β; renal fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27328942      PMCID: PMC5024688          DOI: 10.1096/fj.201500105R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  34 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 2.  Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair.

Authors:  Li Yang; Benjamin D Humphreys; Joseph V Bonventre
Journal:  Contrib Nephrol       Date:  2011-09-09       Impact factor: 1.580

Review 3.  TGFβ signalling in context.

Authors:  Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

Review 4.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

5.  Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.

Authors:  Junwei Yang; Xianghong Zhang; Yingjian Li; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

Review 6.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

Review 7.  Transforming growth factor-β and the progression of renal disease.

Authors:  Ivonne Loeffler; Gunter Wolf
Journal:  Nephrol Dial Transplant       Date:  2013-09-12       Impact factor: 5.992

8.  Protein phosphatase magnesium dependent 1A governs the wound healing-inflammation-angiogenesis cross talk on injury.

Authors:  Zeev Dvashi; Hadas Sar Shalom; Meytal Shohat; Daniella Ben-Meir; Shiran Ferber; Ronit Satchi-Fainaro; Ruth Ashery-Padan; Mordechai Rosner; Arieh S Solomon; Sara Lavi
Journal:  Am J Pathol       Date:  2014-09-06       Impact factor: 4.307

Review 9.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

10.  Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.

Authors:  Rohan Samarakoon; Subhanir S Chitnis; Stephen P Higgins; Craig E Higgins; Joan C Krepinsky; Paul J Higgins
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

View more
  8 in total

1.  Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.

Authors:  Sandybell Anorga; Jessica M Overstreet; Lucas L Falke; Jiaqi Tang; Roel G Goldschmeding; Paul J Higgins; Rohan Samarakoon
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 2.  Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program.

Authors:  Paula J McKeown-Longo; Paul J Higgins
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

3.  Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease via EGFR, p53, and Hippo/YAP/TAZ pathways.

Authors:  Samik Patel; Jiaqi Tang; Jessica M Overstreet; Sandybell Anorga; Fei Lian; Alex Arnouk; Roel Goldschmeding; Paul J Higgins; Rohan Samarakoon
Journal:  FASEB J       Date:  2019-05-16       Impact factor: 5.191

Review 4.  A comprehensive overview of PPM1A: From structure to disease.

Authors:  Mao Li; Xingfeng Xu; Yan Su; Xiaoyun Shao; Yali Zhou; Jianguo Yan
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-03

Review 5.  TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.

Authors:  Craig E Higgins; Jiaqi Tang; Badar M Mian; Stephen P Higgins; Cody C Gifford; David J Conti; Kirstan K Meldrum; Rohan Samarakoon; Paul J Higgins
Journal:  FASEB J       Date:  2019-07-06       Impact factor: 5.834

Review 6.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

Review 7.  Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression.

Authors:  Jiaqi Tang; Cody C Gifford; Rohan Samarakoon; Paul J Higgins
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

8.  PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-β1-receptor signaling.

Authors:  Cody C Gifford; Fei Lian; Jiaqi Tang; Angelica Costello; Roel Goldschmeding; Rohan Samarakoon; Paul J Higgins
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.